The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSchroder Eur.r Regulatory News (SERE)

Share Price Information for Schroder Eur.r (SERE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 61.40
Bid: 61.40
Ask: 62.20
Change: 0.20 (0.33%)
Spread: 0.80 (1.303%)
Open: 62.00
High: 62.00
Low: 61.40
Prev. Close: 61.20
SERE Live PriceLast checked at -
Schroder European Real Estate is an Investment Trust

To provide Shareholders with a regular and attractive level of income return together with the potential for long term income and capital growth through investing in commercial real estate in Continental Europe.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

New lease, refurbishment and forward sale

1 Oct 2020 07:00

RNS Number : 6947A
Schroder Eur Real Est Inv Trust PLC
01 October 2020
 

1 October 2020

SCHRODER EUROPEAN REIT AGREES NEW LEASE, REFURBISHMENT AND FORWARD SALE OF A PARIS OFFICE ASSET FOR c. €104 MILLION

Schroder European Real Estate Investment Trust plc ("SERE" or the "Company"), the company investing in European growth cities, has exchanged contracts to sell its Boulogne-Billancourt office asset in Paris for approximately €104 million, subject to programme and cost. This significant transaction will:

· Deliver a profit, post all acquisition and development costs, of approximately €28 million, representing a net profit of c. 35%, subject to programme and cost;

· Significantly strengthen the balance sheet and Net Asset Value ("NAV") of the Company;

· Provide additional funds for reinvestment and earnings enhancing initiatives.

The sale is structured as a forward funding, with the building being handed over to the purchaser in H1 2022, following completion of a comprehensive refurbishment which is being undertaken by the Company. The refurbishment and sale follows the agreement of a new 10-year pre-let contract with existing tenant Alten in June this year. The rental uplift is 39% higher than the previous rent paid.

The final sale price of approximately €104 million will deliver net sale proceeds of approximately €70 million when completed, after deducting the c. €30 million cost of refurbishing and re-letting the building. This represents a profit on cost of c. 35%. The sale proceeds will be received in stages and the Company expects the NAV to increase incrementally as sale receipts occur. 50% of the price is to be received on exchange of the definitive deed prior to this calendar year end 2020, with the remainder payable in installments over the subsequent 18 months as construction is completed. The overall increase to the most recent published NAV as at 30 June 2020 is expected to be approximately 15%, subject to programme and cost.

The building was originally acquired in 2016 for €37.5 million with the Company identifying an opportunity to create significant value by undertaking a major repositioning of the asset whilst taking advantage of the rapidly improving market dynamics in the Boulogne-Billancourt sub-market of Paris. The transaction reflects the Company's ability to add value through active management of investments acquired in winning high growth locations.

The net sale proceeds strengthen the Company's balance sheet, providing significant operational and financial flexibility. The funds will primarily be redeployed into new earnings enhancing initiatives including new investments.

Sir Julian Berney Bt., Chairman of the Board commented: "This is a transformational transaction, which will be highly accretive to shareholder returns. It is a strong endorsement of the Company's strategy, to identify real estate where we can create significant value for shareholders through asset management, benefiting from our team's local expertise inside the key markets.

"Our focus continues to be on driving the performance of the existing portfolio. This will provide a clear path to income growth and improving long-term shareholder returns and the Company's rating."

Enquiries:

 

Jeff O'Dwyer / Duncan Owen

Schroder Real Estate Investment Management Limited Tel: 020 7658 6000

 

Ria Vavakis

Schroder Investment Management Limited Tel: 020 7658 2371

 

Dido Laurimore/Richard Gotla/Methuselah Tanyanyiwa

FTI Consulting Tel: 020 3727 1000

 

This announcement contains inside information.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DISEAFNEDDPEEAA
Date   Source Headline
15th Apr 20243:00 pmRNSDividend Currency Exchange Rate (Sterling)
11th Apr 20247:00 amRNSProperty Portfolio Valuation
3rd Apr 20247:00 amRNSRefinancing of French Logistics Debt Expiry
25th Mar 20242:00 pmRNSDividend Currency Exchange Rate (SA Rand)
21st Mar 20247:00 amRNSKepler Trust Intelligence: New Research
20th Mar 202410:25 amRNSAnnouncement of NAV and Quarterly Dividend
18th Mar 20242:00 pmRNSResult of AGM
6th Feb 20241:00 pmRNSDirector/PDMR Shareholding
12th Jan 20247:00 amRNSProperty Portfolio Valuation
2nd Jan 20242:00 pmRNSDividend Currency Exchange Rate (Sterling)
20th Dec 20237:00 amRNSEarly Refinancing Completed: St Cloud Office Loan
12th Dec 202312:00 pmRNSAnnual Financial Report on NSM
11th Dec 20231:00 pmRNSDividend Currency Exchange Rate (SA Rand)
6th Dec 202311:20 amRNSDividend Declaration - Correction
6th Dec 20237:02 amRNSNotice of AGM
6th Dec 20237:01 amRNSDividend Declaration
6th Dec 20237:00 amRNSFinal Results
7th Nov 20237:00 amRNSNotice of Full Year Results
23rd Oct 20232:00 pmRNSDividend Currency Exchange Rate (Sterling)
23rd Oct 20237:00 amRNSDirectorate Change
18th Oct 20232:00 pmRNSAppointment of Corporate Broker
16th Oct 20237:00 amRNSProperty Portfolio Valuation
3rd Oct 20232:00 pmRNSDividend Currency Exchange Rate (SA Rand)
2nd Oct 20237:00 amRNSRefinancing Completed of Dutch Portfolio Loan
28th Sep 20237:00 amRNSAnnouncement of NAV and Quarterly Dividend
22nd Sep 20235:13 pmRNSHolding(s) in Company
15th Aug 20237:00 amRNSKepler Trust Intelligence: New Research
24th Jul 20232:00 pmRNSDividend Currency Exchange Rate (Sterling)
21st Jul 202311:06 amRNSDirector/PDMR Shareholding
17th Jul 20237:00 amRNSProperty Portfolio Valuation
3rd Jul 20232:00 pmRNSDividend Currency Exchange Rate (SA Rand)
28th Jun 20237:01 amRNSDividend Declaration
28th Jun 20237:00 amRNSHalf-year Report
9th Jun 20237:00 amRNSNotice of Results
17th Apr 20232:30 pmRNSDividend Currency Exchange Rate (Sterling)
13th Apr 20237:00 amRNSProperty Portfolio Valuation
28th Mar 202310:30 amRNSChange of Auditor
27th Mar 20232:30 pmRNSDividend Currency Exchange Rate (SA Rand)
23rd Mar 20237:00 amRNSAnnouncement of NAV and Dividend
20th Mar 20237:00 amRNSAcquisition of Warehouse in the Netherlands
2nd Feb 202312:41 pmRNSResult of AGM
17th Jan 20237:00 amRNSProperty Portfolio Valuation
3rd Jan 20232:00 pmRNSNotice of Dividend Currency Exchange Rate (GBP)
22nd Dec 20222:00 pmRNSEarly Refinancing of Largest 2023 Debt Expiry
12th Dec 20222:01 pmRNSDividend Currency Exchange Rate (SA Rand)
9th Dec 20221:00 pmRNSUpdate to Dividend Timetable
6th Dec 20227:02 amRNSNotice of AGM
6th Dec 20227:01 amRNSDividend Declaration
6th Dec 20227:00 amRNSFinal Results
24th Nov 202212:00 pmRNSNotice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.